Characterization of the small molecule kinase inhibitor SU11248 
(Sunitinib/SUTENT) in vitro and in vivo – Towards response prediction in cancer 
therapy with kinase inhibitors

Bairlein, Michaela

Lokale TagsFreigabegeschichteDetailsÜbersicht

Characterization of the small molecule kinase inhibitor SU11248 (Sunitinib/SUTENT) in vitro and in vivo – Towards response prediction in cancer therapy with kinase inhibitors

Bairlein, M. (2010). Characterization of the small molecule kinase inhibitor SU11248 (Sunitinib/SUTENT) in vitro and in vivo – Towards response prediction in cancer therapy with kinase inhibitors. PhD Thesis, Technische Universität, München.

Item is Freigegeben

einblenden: alle ausblenden: alle